To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Additional recommended knowledge
N-Nitroso-N-methylurea (CAS No.684-93-5), also known as MNU, is a highly potent carcinogen, mutagen, and teratogen. MNU is an alkylating agent, and exhibits its toxicity by transferring its methyl group to nucleobases in nucleic acids.
Acute exposure to MNU in humans can result in skin and eye irritation, headache, nausea, and vomiting. MNU is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity in experimental animals (IARC 1972, 1978, 1987). Various cancers induced in animal models include: squamous cell carcinomas of the forestomach, sarcomas and gliomas of the brain, adenocarcinomas of the pancreas, leukemia, and lymphomas. However, the actual potential for human exposure is quite limited, as the chemical is not produced or used in large quantities 
MNU is teratogenic and embryotoxic, resulting in craniofacial (cleft palate) and skeletal defects, increased fetal resorption, and fetal growth retardation. Exposure to MNU during pre-implantation, post-implantation, organogenesis, or by paternal exposure can result in these effects.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "N-Nitroso-N-Methylurea". A list of authors is available in Wikipedia.|